Pharmaceutical substance:

Butamirate citrate

Pharmaceutical product:

Acidi salicylici unguentum 1% cum etheroleo lavandulae

Technical notes for pharmaceutical substances and products submitted for public inquiry (attached text)

The draft concerns the following active pharmaceutical ingredient (API):

Butamirate citrate

The draft concerns the following pharmaceutical product:

Acidi salicylici unguentum 1% cum etheroleo lavandulae

The draft concerns the following API:

Butamirate citrate

The draft concerns the following pharmaceutical product:

Acidi salicylici unguentum 1% cum etheroleo lavandulae

Keywords: active pharmaceutical ingredient, Butamirate citrate, pharmaceutical product, Acidi salicylici unguentum, etheroleo lavandulae

Part of the draft was previously notified under 2017/124/CZ. However, on 27 November 2017, the notification procedure was stopped due to withdrawal by the Member State. Significant changes were to be made to the draft, which have now been incorporated.